IndieBio Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Professionals
-
10
- Investments
-
246
- Portfolio
-
169
- Exits
-
25
IndieBio General Information
Description
Founded in 2014, IndieBio is a start-up accelerator based in San Francisco, California. The firm primarily focuses on early-stage biotech companies
Contact Information
Website
www.indiebio.co
Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Other Investor Types
Venture Capital
Primary Office
- 479 Jessie Street
- San Francisco, CA 94103
- United States
IndieBio Investments (246)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cybele Microbiome | 13-Dec-2022 | Seed Round | Personal Products | Product Development | ||
| 00000 000000000 | 12-Dec-2022 | 0000 00000 | Plant Textiles | Generating Revenue | ||
| 00000 | 09-Dec-2022 | 00000 00000 | 000.00 | Monitoring Equipment | Generating Revenue | |
| 0000000000 | 09-Dec-2022 | 0000 00000 | Food Products | Generating Revenue | ||
| 0000000000 | 01-Dec-2022 | 00000 00000 | 000 | Food Products | Generating Revenue | |
| 00000000 | 29-Nov-2022 | 00000 00000 | 00.00 | Food Products | Generating Revenue | |
| 00000000 | 23-Nov-2022 | 0000 00000 | 00.000 | Household Products | Generating Revenue | |
| 0000000000 | 17-Nov-2022 | 0000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
| Biofluff | 16-Nov-2022 | Seed Round | 00000 | Plant Textiles | Generating Revenue | |
| BioSapien | 01-Nov-2022 | Early Stage VC | 0000 | Drug Delivery | Generating Revenue |
IndieBio Exits (25)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| CellCrine | 16-Nov-2022 | Out of Business | |
| 0000000000 | 04-Oct-2022 | 000000000000000000 | |
| 0000000 0000000000 | 07-Jul-2022 | 000 00 00000000 | |
| 00000 00000000 | 12-Jun-2022 | 000 00 00000000 | |
| 00000 000000000000 | 07-Apr-2022 | 000000000000000000 | |
| 000000000 00000000 | 25-Jan-2022 | 000000000000000000 | |
| 000000 0000000 | 22-Aug-2021 | 000 00 00000000 | |
| 000000 000 | 19-Jul-2021 | 000 00 00000000 | |
| GEAenzymes | 04-Dec-2020 | Out of Business | |
| MYi Diagnostics | 05-Aug-2020 | Out of Business |
IndieBio Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
IndieBio Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Po Bronson | Managing Director & General Partner | 000 | 0 | 0 | San Francisco, CA |
| Alex Kopelyan | Senior Director & Partner | 0 | 0 | 0 | San Francisco, CA |
| Parikshit Sharma | Partner | 0 | San Francisco, CA | ||
| Sabriya Stukes | Chief Scientific Officer | New York, NY | |||
| Westley Dang Ph.D | Program Director | San Francisco, CA |
IndieBio Co-Investors (246)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| SOSV | 119 | 0 | 0 |
|
|
| Genesis Consortium | 0 | 0 |
|
|
|
| CPT Capital | 0 |
|
|
||
| Grid Exponential | 0 | 0 |
|
|
|
| Social Starts | 0 | 0 |
|
|